{{Drugbox
| Watchedfields = changed
| verifiedrevid = 464206617
| IUPAC_name = (3''S'',4''R'')-3-Ethyl-4-((1-methyl-1''H''-imidazol-5-yl)methyl)dihydrofuran-2(3''H'')-one
| image = Pilocarpine.svg
| width = 180
| image2 = Pilocarpine ball-and-stick model.png

<!--Clinical data-->
| tradename = Isopto Carpine, Salagen, others
| Drugs.com = {{drugs.com|monograph|pilocarpine}}
| MedlinePlus = a608039
| pregnancy_AU = B3
| pregnancy_US = C
| legal_AU = S4
| legal_US = Rx-only
| legal_UK = POM
| routes_of_administration = 眼液、口服

<!--Pharmacokinetic data-->
| bioavailability =   
| protein_bound =  
| metabolism =  
| elimination_half-life = 0.76 hours (5 mg), 1.35 hours (10 mg)<ref>{{cite journal |title=Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer |author1=Mervyn Gornitsky |author2=George Shenouda |author3=Khalil Sultanem |author4=Howard Katz |author5=Michael Hier |author6=Martin Black |author7=Ana M Velly |journal=Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology |volume=98 |issue=1 |pages=45–52 |year=2004 |url=http://www.journals.elsevierhealth.com/periodicals/ymoe/article/S1079-2104%2804%2900285-9/abstract}}</ref>
| excretion = 尿液

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 92-13-7
| CAS_supplemental = <br/>{{CAS|54-71-7}} ([[hydrochloride|hydrochloride]]) <!-- Also CAS verified -->
| ATC_prefix = N07
| ATC_suffix = AX01
| ATC_supplemental =  {{ATC|S01|EB01}}
| PubChem = 5910
| IUPHAR_ligand = 305
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01085
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 5699
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 01MI4Q9DI3
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00525
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 8207
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 550

<!--Chemical data-->
| C=11 | H=16 | N=2 | O=2
| molecular_weight = 208.257 g/mol
| smiles = O=C2OC[C@H](Cc1n(cnc1)C)[C@@H]2CC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C11H16N2O2/c1-3-10-8(6-15-11(10)14)4-9-5-12-7-13(9)2/h5,7-8,10H,3-4,6H2,1-2H3/t8-,10-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = QCHFTSOMWOSFHM-WPRPVWTQSA-N
}}
{{medical}}

'''匹魯卡品'''（[[INN|INN]]：Pilocarpine）是一種[[藥物|藥物]]，又名'''毛果芸香鹼'''；是從[[芸香屬|毛果芸香屬]]植物葉中提出的[[生物鹼|生物鹼]]，是一種[[膽鹼|膽鹼]]類之副交感神經促進劑，一般用於治疗原发性[[青光眼|青光眼]]<ref>[http://www.med66.com/zhuguanyaoshi/zz1706111712.shtml 毛果芸香碱和阿托品对眼的作用总结 医学教育网]</ref>及[[口乾|口腔乾燥]]<ref>[http://www.sle.org.tw/ezcatfiles/nw19/img/img/400/5602.pdf 不再望梅止渴─淺談緩解乾燥症新藥"Pilocarpine"] 臺北市立聯合醫院仁愛院區
過敏免疫風濕科 蔡明翰醫師</ref>。毛果芸香鹼於1874年被分離出<ref name=Sn2005>{{cite book|last1=Sneader|first1=Walter|title=Drug Discovery: A History|date=2005|publisher=John Wiley & Sons|isbn=9780471899792|page=98|url=https://books.google.ca/books?id=Cb6BOkj9fK4C&pg=PA98|language=en|deadurl=no|archiveurl=https://web.archive.org/web/20161229100153/https://books.google.ca/books?id=Cb6BOkj9fK4C&pg=PA98|archivedate=2016-12-29|df=}}</ref>，它被[[世界衛生組織|世界衛生組織]]列為[[世界衛生組織基本藥物標準清單|基本藥物清單]]之一<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=13 December 2016|df=}}</ref>。
== 參考文獻 ==
{{reflist}}

{{抗青光眼制剂及缩瞳药}}

[[Category:生物鹼|Category:生物鹼]]
[[Category:世界衛生組織基本藥物|Category:世界衛生組織基本藥物]]
[[Category:眼科用药|Category:眼科用药]]
[[Category:咪唑|Category:咪唑]]
[[Category:四氢呋喃|Category:四氢呋喃]]
[[Category:内酯|Category:内酯]]
[[Category:膽鹼能藥物|Category:膽鹼能藥物]]
[[Category:存在于芸香科中的生物碱类|Category:存在于芸香科中的生物碱类]]